SCHEMBL741926

SCHEMBL741926

CN(C)c1ccc(C(=O)Nc2n[nH]c3sc(C(=O)NC(C)(C)c4ccccc4)cc23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 3/20 0.52
ABL1 P00519 2/20 0.50
BCR P11274 2/20 0.50
FLT3 P36888 4/20 0.47
MAP4K4 O95819 3/20 0.42
ROCK2 O75116 3/20 0.42
MELK Q14680 2/20 0.42
MINK1 Q8N4C8 2/20 0.42
STK17A Q9UEE5 2/20 0.42
CDK2 P24941 2/20 0.42
CLK2 P49760 2/20 0.42
CDK5 Q00535 2/20 0.42
MAP4K2 Q12851 2/20 0.42
DYRK1A Q13627 2/20 0.42
MAP4K5 Q9Y4K4 2/20 0.42
CDC7 O00311 1/20 0.42
DAPK3 O43293 1/20 0.42
PAK4 O96013 1/20 0.42
PRKACA P17612 1/20 0.42
CSNK1A1 P48729 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740292 0.91 AURKA (0.55) AURKAABL1BCRCDK2CDK7
SCHEMBL738866 0.89 AURKA (0.53) AURKAABL1BCRFLT3MAP4K4
SCHEMBL741311 0.89 AURKA (0.53) AURKAABL1BCRFLT3MELK
SCHEMBL739669 0.88 ABL1 (0.53) AURKAABL1BCRFLT3MAP4K4
SCHEMBL740809 0.88 AURKA (0.52) AURKAABL1BCRMAP4K4ROCK2
SCHEMBL739779 0.87 AURKA (0.52) AURKAABL1BCRFLT3ROCK2
SCHEMBL741609 0.87 AURKA (0.52) AURKAABL1BCRROCK2CDK2
SCHEMBL743719 0.86 ABL1 (0.55) AURKAABL1BCRFLT3ROCK2
SCHEMBL739853 0.86 AURKA (0.51) AURKAABL1BCRROCK2CDK7
SCHEMBL742313 0.85 ABL1 (0.51) AURKAABL1BCRFLT3MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed